COMP <GO>
VIAV vs SLAB // RSI-14 & 200D SMA MOMENTUM
Viavi Solutions Inc. (NASDAQ) VS. Silicon Laboratories Inc. (NASDAQ) • 15-METRIC TALLY: VIAV 7
— SLAB 5
▲ RSI-14 & 200D SMA MOMENTUM LEADER: SLAB
LAST: $29.92 (-10.20%) • MKT CAP: $8.25B
rsi-technicals
44.1
LAST: $222.45 (+0.05%) • MKT CAP: $7.42B
rsi-technicals
61.8
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VIAV VS. SLAB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VIAV | SLAB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.70% | 58.20% | -0.50 | SLAB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.40% | -6.90% | +16.30 | VIAV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 63.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.00% | 0.89% | +0.11 | VIAV | /fcf-yield <GO> |
| Operating Margin | 6.90% | -9.00% | +15.90 | VIAV | /operating-margins <GO> |
| Net Profit Margin | -2.00% | -8.30% | +6.30 | VIAV | /net-margins <GO> |
| Revenue Growth (YoY) | 40.00% | 34.30% | +5.70 | VIAV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 26.00 | -25.55 | SLAB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | SLAB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 44.1 | 61.8 | -17.70 | SLAB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.30 | 1.42 | -0.12 | SLAB | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 31.0x | -9.00 | VIAV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.25B | $7.42B | $832.3M | VIAV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VIAV REV | SLAB REV | VIAV GROSS % | SLAB GROSS % | VIAV FCF | SLAB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | $784.8M | 57.7% | 58.2% | $82.8M | $65.8M |
| FY 2024 | $1.08B | $584.4M | 57.3% | 53.4% | $62.0M | -$25.7M |
| FY 2023 | $1.11B | $782.3M | — | — | $64.3M | -$65.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VIAV // BETA 1.30
SLAB // BETA 1.42